id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2018-E-4324-0003,FDA,FDA-2018-E-4324,Determination of Regulatory Review Period for Purposes of Patent Extension; ANGELMED GUARDIAN SYSTEM,Notice,Determinations,2022-11-07T05:00:00Z,2022,11,2022-11-07T05:00:00Z,2023-01-07T04:59:59Z,2022-11-07T13:39:11Z,2022-24216,0,0,0900006485492c7c
FDA-2018-E-4324-0002,FDA,FDA-2018-E-4324,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2022-09-08T04:00:00Z,2022,9,2022-09-08T04:00:00Z,,2022-09-08T16:11:42Z,,0,0,09000064852cdc71